Research output per year
Research output per year
Personal profile
Fields of Science
- 317 Pharmacy
-
New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases
Svarcbahs, R., Julku, U., Kilpelainen, T., Kyyrö, M., Jäntti, M. & Myohänen, T. T., Mar 2019, In: Biochemical Pharmacology. 161, p. 113-120 8 p.Research output: Contribution to journal › Review Article › peer-review
Open AccessFile -
Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers
Dokleja, L., Hannula, M. J. & Myohänen, T. T., 7 Nov 2014, In: Neuroscience Letters. 583, p. 37-42 6 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula, M. J., Myöhänen, T. T., Tenorio-Laranga, J., Männistö, P. T. & Garcia Horsman, J. A., 9 Jul 2013, In: Neuroscience. 242, p. 140-150 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
Myöhänen, T. T., Hannula, M. J., Van Elzen, R., Gerard, M., Van der Veken, P., Garcia Horsman, J. A., Baekelandt, V., Männistö, P. T. & Lambeir, A. M., 10 Jan 2012, In: British Journal of Pharmacology. 166, 3, p. 1097-1113 17 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Sequential expression, activity and nuclear localization of prolyl oligopeptidase in the developing rat brain
Hannula, M. J., Männistö, P. T. & Myöhänen, T. T., 2011, In: Developmental Neuroscience. 33, 1, p. 38-47 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Projects
- 1 Finished